ORTFX
Price
$10.31
Change
-$0.00 (-0.00%)
Updated
Jun 11 closing price
Net Assets
270.55M
UTAHX
Price
$9.71
Change
+$0.01 (+0.10%)
Updated
Jun 12 closing price
Net Assets
199.11M
Interact to see
Advertisement

ORTFX vs UTAHX

Header iconORTFX vs UTAHX Comparison
Open Charts ORTFX vs UTAHXBanner chart's image
ORTFX vs UTAHX Comparison Chart in %
View a ticker or compare two or three
VS
ORTFX vs. UTAHX commentary
Jun 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORTFX is a Hold and UTAHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ORTFX has more cash in the bank: 271M vs. UTAHX (199M). UTAHX pays higher dividends than ORTFX: UTAHX (3.59) vs ORTFX (3.07). ORTFX was incepted earlier than UTAHX: ORTFX (40 years) vs UTAHX (34 years). UTAHX (0.78) is less costly to investors than ORTFX (0.69). UTAHX is a more actively managed with annual turnover of: 74.00 vs. ORTFX (64.00). ORTFX (3%) and UTAHX (3%) have equivalent initial investment costs. ORTFX (1000) and UTAHX (1000) have matching initial minimum investment requirements. UTAHX annual gain was more profitable for investors over the last year : 6.78 vs. ORTFX (6.12). UTAHX return over 5 years is better than : 3.32 vs. ORTFX (2.07).
ORTFXUTAHXORTFX / UTAHX
Total Expense Ratio0.690.7888%
Annual Report Gross Expense Ratio0.690.7888%
Fund Existence40 years34 years-
Gain YTD1.1941.81766%
Front Load3%3%100%
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets271M199M136%
Annual Yield % from dividends3.073.5985%
Returns for 1 year6.126.7890%
Returns for 3 years8.6610.9079%
Returns for 5 years2.073.3262%
Returns for 10 years12.4216.6675%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLL3.320.42
+14.48%
Full House Resorts
AMCR40.600.68
+1.70%
Amcor plc
NABL3.210.02
+0.63%
N-able
BEAM29.01-0.40
-1.36%
Beam Therapeutics
FEED0.85-0.03
-3.43%
ENvue Medical Inc